Desire for sweet foods decreased by 14.0 to 19.5 points as early as week 4 after reaching this dose
10.1016/S0891-5849(99)00090-8 72 ParkY
A provider will adjust your timeline based on your progress and lab results
Treatment duration in weeks (Pearson chi-square = 20.5, P = 0.15, np-trend by year z = 1.29, P = 0.196) and follow-up duration in weeks (Pearson chi-square = 16.9, P = 0.32, np-trend by year z = 1.91, P = 0.056) were comparable across studies and over time
Other anomalies observed include visual defects (63%), cardiac defects (51%), constipation (51%), frequent infections (47%), behavioural problems (39%), sleep disturbances (37%), and microcephaly (31%) (Kennedy et al, 2019)
Huang J, Wang X, Li N, Fan W, Li X, Zhou Q, et al